Dove Medical Supply LLC

Dove Medical Supply LLC, a woman-owned, minority-owned small disadvantaged business based in Summerfield, North Carolina, supplies laboratory and medical products to the federal government as a prime contractor on a high-volume, task-order-driven basis. Operating as a for-profit limited liability company under primary NAICS 424210 (Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers), Dove competes exclusively full-and-open without set-aside designations, despite holding the SBA certifications that would enable 8(a) or WOSB set-aside competition.

Dove's federal footprint is almost entirely concentrated in medical supply distribution under a single dominant vehicle: the Defense Logistics Agency Troop Support Medical Indefinite Delivery Contract SPE2DE21D0022, a $400 million single-award IDIQ established September 15, 2021, and completing September 14, 2026. This contract anchors 94,902 task orders (combined potential value $110.8 million) and represents the overwhelming bulk of Dove's federal revenue. The remaining activity flows through four older DLA Troop Support Medical IDIQs (SPE2DE17D0018 with 25,076 task orders worth $48.2 million, SPE2DE14D0005 with 22,476 task orders worth $25.6 million, SPE2DE20D0008 with 19,366 task orders worth $45.9 million, and SPE2DH21D0065 with 2,278 task orders worth $11.7 million). All five vehicles are DLA-issued with no set-aside category applied, and all task orders visible in the source are fixed-price delivery orders with economic price adjustment.

Customer concentration is extreme. The Defense Logistics Agency Troop Support Medical accounts for 164,202 awards (100% of task-order volume) and $827.8 million in combined potential value (nearly 100% of the dollar total). Subsidiary federal customers — the Department of Veterans Affairs VISNs 6 and 10, GSA, and the Navy Bureau of Medicine and Surgery — account for 20 awards totaling roughly $1.3 million. Dove has served 13 distinct agencies, but DLA is the sole meaningful customer.

Capability scope is narrow and granular. Dove fulfills individual delivery orders for single medical and laboratory products or small product runs: diagnostic test kits (BinaxNOW COVID/Flu A & B combos, Quidel Strep A+, malaria tests, rapid HIV), laboratory reagents and controls (I-STAT calibration verification, hemocue systems and microcuvettes, comprehensive metabolic panels, multi-chemistry analyzer controls), personal protective equipment (nitrile examination gloves, N95 respirators, germicidal wipes and disposable disinfectants), bloodwork and specimen collection supplies (vacutainers, serum tubes, blood collection sets, needles, tourniquets, gauze, bandages), thermal packs and general medical consumables (instant cold packs, heat packs, microscope slides, zip bags, paper grocery bags), and specialized instrumentation (HemoCue analyzers, dental radiography sensors, Draeger X-Act diagnostic equipment, Marco examination stands). Representative April 2026 delivery orders ranged from under $100 (cold packs, alcohol prep pads) to $18,821 (HemoCue HB 301 System), with most orders in the $200–$2,000 ceiling range. The source lists 164,230 awards spanning multiple years; recent award density (8,221 awards in 2026 through mid-April, 24,489 in 2025) indicates thousands of small transactional purchases annually.

Recent activity shows steady baseline volume. Awards per year tracked at 16,441 (2022), 22,671 (2023), 22,340 (2024), and 24,489 (2025), with 8,221 awards already recorded in 2026 through mid-April. Combined potential value across all awards stands at $829.3 million, with $246.7 million obligated (30% realization rate). The recompete cliff inside the next twenty-four months carries negligible exposure — only one award ($800 potential value) completes in that window — because the dominant IDIQ does not expire until September 14, 2026, and the source carries no indication of recompete solicitation activity.

Dove operates as a 100% prime contractor with no recorded subcontract activity in the source data. It does not appear as a subcontractor on other primes' federal work, nor does the source evidence sub-awards in its own name. The company's entire federal presence is delivery-order fulfillment against DLA IDIQs, with no parent vehicles, teaming relationships, or indirect federal engagement.

The vendor's PSC footprint mirrors its NAICS profile: 149,704 awards fall under Laboratory Equipment and Supplies (PSC 6510), 12,347 under Medical and Surgical Instruments, Equipment, and Supplies (PSC 6520), and 2,151 under Hospital Furniture, Equipment, Utensils, and Supplies (PSC 7210). This is a commodity distribution play anchored to DLA's standing blanket-purchase model for medical-supply replenishment.

Distributor of laboratory, medical, surgical, pharmaceutical equipment, supplies and disposables with 35 years experience. Qualified trained knowledgeable staff.